The U.S. Food and Drug Administration has declined to approve an injectable version of Johnson & Johnson's drug Rybrevant for ...

Over a 45-years span — between 1975 and 2020 — improvements in cancer screenings and prevention strategies have reduced ...

A new molecular imaging agent can accurately identify a crucial biomarker found among many different types of cancer. Precise ...

Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future ...

Teos Therapeutics has potential lung cancer treatment despite issues and strong financial position. Read here to know why we ...

With tumor reduction seen in 48% of the 33 patients studied, the combination treatment had an overall response rate of 21% in ...

Monotherapy activity with inhaled KB707 provides further evidence of successful repeat administration of HSV-1 based inhaled lung gene delivery and builds on recent clinical data update for CF and AAT ...

China's homegrown medicines are expected to play a more important role in tumor treatment as domestic researchers and ...

From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.

Liam Handley, 36, visited his GP in 2020 when he experienced worsening chest pains which were dismissed as stress and anxiety ...

The FDA granted breakthrough therapy designation to sacituzumab govitecan for patients with ES-SCLC progressing on platinum ...

Liam Handley - who had suffered from anxiety for much of his life - went to his GP with chest pains, which his doctor put ...